Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
mastodon.ie is one of the many independent Mastodon servers you can use to participate in the fediverse.
Irish Mastodon - run from Ireland, we welcome all who respect the community rules and members.

Administered by:

Server stats:

1.7K
active users

mastodon.ie: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.8

#wallstreet

3 posts3 participants0 posts today
Public
CaliCarol

pca.st/episode/deeaddf7-7cca-4

This is the first time someone has told the truth about Trump and tariffs. To paraphrase, Trump is a megalomaniacal sadist and enjoys hurting other countries. There's no strategy. Oh, and China tried to talk sense into the regime before the imposition of tariffs and were rebuffed. So this mess is madness + incompetence. Someone (hello Congress) needs to take the keys away. Oh, and Wall Street is deluding itself as usual.

pca.stWeb Player - Pocket CastsListen to your favorite podcasts online, in your browser. Discover the world's most powerful podcast player.
#China#Tariffs#WallStreet
Public *
WYM Mod

Stephanie Ruhle uncovers a haunting sentiment of “paralysis, anger, and devastation” among Wall Street and Main Street due to Trump's economic policies. As forecasts indicate a contraction, disillusionment grows among past supporters reacting to tariffs and deceptive blame towards Biden. Ruhle highlights the average American's awareness amidst this discontent, showcasing a critical loss of credibility for Trump. Explore her insights here: alternet.org/americans-not-buy. #Economy #StephanieRuhle #Trump #WallStreet #MainStreet #GDP #Tariffs #Credibility #AmericanPeople

Alternet.org · 'Not telling the truth': MSNBC host says only 'low information' voters believe Trump's liesBy Adam Lynch
Public
Miguel Afonso Caetano

"Chief Executives don’t usually brag about paying high tax rates.
But with pharma tariffs looming, being a tax sucker is suddenly a badge of safety in the industry. That isn’t because Wall Street is suddenly in love with taxes. Rather, with so much uncertainty, investors are prizing biotech companies that base their intellectual property and manufacturing in the U.S., which up until now often meant higher taxes.

On a Thursday earnings call, Gilead Sciences Chief Executive Daniel O’Day proudly pointed out that the biotech’s corporate tax rate of approximately 20% “reflects the fact that the substantial majority of our intellectual property is already registered in the United States.”

Before the Trump era, many pharma and biotech firms established intellectual property and manufacturing operations in low-tax hubs such as Ireland. This allowed them to reduce their tax bills through transfer pricing. Essentially, the Irish unit of the company sells the drug to a U.S. unit at a high internal “transfer price,” enabling the parent company to book most of the profit in the lower-tax jurisdiction. (Ireland currently offers a headline 15% corporate tax rate to big companies, compared with 21% in the U.S.) On paper, the U.S. unit appears to earn little—even though the end-sales are largely happening in America.

While the 2017 tax overhaul under Trump was meant to curb offshore profit shifting, in practice it left key loopholes intact.

Now the second Trump administration appears to be preparing to use tariffs to target the practice, with the goal of inducing companies to increase manufacturing in the U.S. Earlier this month, the Trump administration—which has repeatedly lambasted Ireland for luring American pharma companies—announced probes into pharmaceutical imports, citing national-security concerns."

wsj.com/finance/stocks/wall-st

#USA#Trump#Tariffs
Public
Miguel Afonso Caetano

"The most important story is that on Monday, in a D.C. district court, Judge Amit Mehta started hearings on how to restructure Google to thwart its unlawful monopoly. Two floors down, Judge James Boasberg continued the antitrust trial between the government and Meta. Never before have two trillion dollar plus companies been put on trial at the same time, in the same court house.

And yet, on Thursday, Google had its quarterly investing call where it unveiled its gargantuan earnings of $34 billion in the past three months, and discussed its future prospects with Wall Street researchers. Not a single analyst even mentioned the risk of antitrust or asked a question about it. One of them noted a stat that came out of the trial, which is user pick-up of the search firm’s AI app, Gemini, so they are clearly paying attention to the trial. They just don’t seem to think it matters. That’s true for big investors in Meta as well.

Why does antitrust seem irrelevant to Wall Street? It’s certainly not the substance of the trials."

thebignewsletter.com/p/monopol

#USA#Google#Meta
Continued thread
Public
William Lindsey :toad:

"Tesla’s stock has undergone a withering sell-off, and the CNBC All-America Economic survey finds more than 47% of the public have a negative view of the company. Another 27% are positive on the electric vehicle maker, while 24% are neutral."

~ Steve Liesman

#Musk #Tesla #Trump #economy #StockMarkets #tariffs #Dow #recession #WallStreet
/15

cnbc.com/2025/04/22/about-half.

CNBCAbout half of Americans have a negative view on Tesla and Elon Musk, CNBC survey findsThe broad public and investors have something in common these days: They don't have a lot of love for either Tesla or CEO Elon Musk.
Continued thread
Public
William Lindsey :toad:

"I want to suggest today that what we are seeing on Wall Street and in markets around the world is the sudden realization that the president is mentally unstable – that he has dementia, probably – and as a result of that realization, investors no longer have any faith in Donald Trump."

~ John Stoehr

#Musk #Tesla #Trump #economy #StockMarkets #tariffs #Dow #recession #WallStreet
/14

alternet.org/alternet-exclusiv

Alternet.org · Wall Street seems to have decided that Trump is mentally unstableBy John Stoehr
ExploreLive feeds
About